About This EventInspireMD (Nasdaq: NSPR), developer of the CGuard® Prime Carotid Stent System, visits the Nasdaq MarketSite in Times Square to celebrate its recent FDA approval and U.S. launch ...

The company noted that it is evaluating the potential financial impact of a permanent withdrawal of the IXCHIQ license in the United States but is not modifying its revenue guidance at this time.